Tag: ASCO

Allogene set to disrupt CAR-T market with pivotal trial of ‘off the shelf’ therapy

May 21, 2021

Via: Pharmaphorum

Data announced ahead of this year’s American Society of Clinical Oncology (ASCO) conference suggest that Gilead and CAR-T rivals Bristol-Myers Squibb and Novartis better watch their backs as Allogene announced plans for a pivotal study this year. Allogeneic or “off […]

Clinical Trials, Research and Development

Study: Some Cancer Clinical Trials Being Spun in a Positive Light at Meetings Despite Negative Results

April 17, 2020

Via: BioSpace

A recent study published in JAMA Oncology found that although about a third of cancer clinical trials failed to meet their primary endpoints, at oncology meetings they tend to be spun in a positive light. For example, in 91 negative […]

Tag: ASCO

Allogene set to disrupt CAR-T market with pivotal trial of ‘off the shelf’ therapy

Study: Some Cancer Clinical Trials Being Spun in a Positive Light at Meetings Despite Negative Results

Latest Publications

FDA Inspections Face Overhaul

FDA Adds Warning to Ozempic Label About Risk for Blocked Intestines

Inside Bavarian Nordic’s late-stage stumbles — and drive to become a vaccine giant

Tag: ASCO

Allogene set to disrupt CAR-T market with pivotal trial of ‘off the shelf’ therapy

Study: Some Cancer Clinical Trials Being Spun in a Positive Light at Meetings Despite Negative Results

Trending

Tags

Latest Publications

FDA Inspections Face Overhaul

FDA Adds Warning to Ozempic Label About Risk for Blocked Intestines

Inside Bavarian Nordic’s late-stage stumbles — and drive to become a vaccine giant